Gencay M.Dereli D.Ertem E.Serter D.Puolakkainen M.Saikku P.Boydak B.Dereli S.Ă–zbakkaloglu B.Yorgancioglu A.Tez E.2024-07-222024-07-22199803932990http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/20647Serological markers for Chlamydia pneumoniae were investigated by using the microimmunofluorescence (MIF) test in various age and patient groups in a specific area in Turkey. IgG seropositivity to C. pneumoniae was 64.3% and 18.7% in healthy adults and children, respectively. The highest positivity rate (77%) was in the 15-19 age group. Among the groups investigated, serological findings revealed a possible etiological association between C. pneumoniae and the clinical condition in the groups with acute myocardial infarction, atypical pneumoniae and chronic obstructive pulmonary disease.EnglishAdolescentAdultAgedAged, 80 and overAntibodies, BacterialChildChild, PreschoolChlamydia InfectionsChlamydophila pneumoniaeFemaleFluorescent Antibody TechniqueHumansImmunoglobulin AImmunoglobulin GImmunoglobulin MInfantLung Diseases, ObstructiveMaleMiddle AgedMyocardial InfarctionPneumoniaPrevalenceRisk FactorsSeroepidemiologic StudiesTurkeyimmunoglobulin A antibodyimmunoglobulin G antibodyimmunoglobulin M antibodymarkeracute heart infarctionadolescentadultageagedarticlechildChlamydophila pneumoniaechronic obstructive lung diseaseclinical trialcontrolled studyfemalehumanhuman experimenthuman tissueimmunofluorescence testinfantmajor clinical studymalenormal humanrisk factorseroprevalenceTurkey (republic)Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, TurkeyArticle10.1023/A:1007404315879